Atlas Trials

Phase II Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes

Clinical trial NCT02005848 · COMPLETED

Trial details

NCT number
NCT02005848
Sponsor
Kamada, Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
New Onset Type-1 Diabetes
Start date
2014-04-01
Primary completion
2017-02-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.